Please find the attached Certifiacte under Regulation 74(5) of DP Regulations 2018
Awaiting price reaction for this filing.
Raymed Labs Limited (BSE Scrip Code: 531207) has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the fourth quarter and financial year ended 31st March 2025. The certificate, issued by their Registrar and Share Transfer Agent Beetal Financial & Computer Services Pvt Ltd dated 4th April 2025, confirms that all securities received from Depository Participants for dematerialization during the quarter were properly processed, listed on the stock exchange, and that the corresponding physical certificates were mutilated and cancelled within 15 days. The names of depositories have been substituted as registered owners in the company's register of members. The filing was signed by Director Prashant Nathmal Bajaj on 11th April 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms that the company's share dematerialization process is functioning correctly as required by SEBI regulations.